[Multidrug resistance of neoplastic cells--facts and hypotheses].
Grzelakowska-Sztabert
B
B
Zakład Biochemii Komórki, Instytut Biologii Doświadczalnej im. M. Nenckiego, PAN, Warszawa.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D002135:Calcium-Binding Proteins / Q000502:physiology; D004250:DNA Topoisomerases, Type II / Q000502:physiology; D004351:Drug Resistance / Q000235:genetics / Q000502:physiology*; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D005978:Glutathione / Q000502:physiology; D005982:Glutathione Transferase / Q000502:physiology; D006801:Humans; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000502:physiology*; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002135:Calcium-Binding Proteins; D008562:Membrane Glycoproteins; C503113:SRI protein, human; D005982:Glutathione Transferase; D004250:DNA Topoisomerases, Type II; D005978:Glutathione
Oporność wielolekowa komórek nowotworowych--fakty i hipotezy.